Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors.
about
Impact of Adjuvant Endocrine Therapy on Quality of Life and Symptoms: Observational Data Over 12 Months From the Mind-Body StudyEarly discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: a randomized trial.Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia?Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer.Acupuncture for Aromatase Inhibitor-Induced Arthralgia: A Systematic Review.Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors.Body mass index and menopausal disorders during menopause affect vasomotor symptoms of postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.Joint symptoms and health-related quality of life in postmenopausal women with breast cancer who completed 5 years of anastrozole.Development and validation of the Penn Arthralgia Aging Scale among breast cancer survivors.Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens.Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.
P2860
Q30758966-89B3D82A-73A2-4465-B838-6E48B1CDF915Q33756969-6B5842D2-0AA8-4B40-804C-5D0977E937DBQ34551060-FD5E8BF1-2E64-46E3-8BEB-752C82AFFC3CQ35857652-2336F5EF-5FC7-48C7-B093-E501320789F8Q36884366-E7669AC9-2274-4468-A371-849E50420AB0Q38556576-3E4495E2-A0FB-4B97-8495-15A285A27667Q39444220-58DAD64F-4BC2-433F-A8BE-70E869A6B321Q40412003-9CD59062-0394-4D4C-857A-C96C00A3F0FAQ40759613-B090AA54-CE49-4E8F-BFC7-DD0EEEC67D83Q41575423-52734689-C3EA-4FE9-80DA-DE252BAB5999Q44346721-41780ED4-E87E-4A00-8AA8-09CCB9754D84Q47624971-67472897-945D-4A60-AAA1-A85BA8D0371EQ47656859-0A7A1D61-1CF7-47C7-8E67-D469153FE0E7
P2860
Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Joint pain severity predicts p ...... rs in breast cancer survivors.
@ast
Joint pain severity predicts p ...... rs in breast cancer survivors.
@en
Joint pain severity predicts p ...... rs in breast cancer survivors.
@nl
type
label
Joint pain severity predicts p ...... rs in breast cancer survivors.
@ast
Joint pain severity predicts p ...... rs in breast cancer survivors.
@en
Joint pain severity predicts p ...... rs in breast cancer survivors.
@nl
prefLabel
Joint pain severity predicts p ...... rs in breast cancer survivors.
@ast
Joint pain severity predicts p ...... rs in breast cancer survivors.
@en
Joint pain severity predicts p ...... rs in breast cancer survivors.
@nl
P2093
P2860
P356
P1433
P1476
Joint pain severity predicts p ...... rs in breast cancer survivors.
@en
P2093
Angela DeMichele
Carrie T Stricker
John T Farrar
Kannie Chim
Robert Gross
Sharon X Xie
P2860
P2888
P356
10.1186/1471-2407-13-401
P407
P577
2013-09-03T00:00:00Z
P5875
P6179
1042276320